Fenretinide in Treating Patients With Leukoplakia of the Mouth
Status:
Completed
Trial end date:
2004-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the
development of or treat early cancer. Fenretinide may be an effective drug in treating
leukoplakia.
PURPOSE: Randomized phase II trial to study the effectiveness of fenretinide in treating
patients who have leukoplakia of the mouth.